Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Asthma Inhalers to Incorporate Adherence-friendly Features

Asthma Inhalers Evolving to Incorporate Adherence-friendly Features

Greystone Research Associates Examines New-Generation Devices and their Impact on Patient Behavior

Amherst, NH, February 11, 2013 – The inhaled respiratory market represents one of the largest categories of drug spending, with continuing growth due to the increasing diagnosis of conditions such as asthma and COPD. As the incidence of these conditions increases, there exists a growing and significant opportunity to improve and expand current treatment of diseases of the upper respiratory tract.

Asthma continues to be a health segment that presents challenges to the caregiver community. Patient adherence with prescribing instructions and treatment protocols remains sub-optimal across all patient categories, but particularly for the young and the elderly. This has led to significant interest on the part of device and combination product providers directed toward the development easier-to-use inhalers. The new generation of oral asthma inhalers incorporates features and design elements that address this initiative, enabling devices that are more user-friendly and safe, and that as a result support the goal of improved patient adherence.

The current trend in asthma inhaler evolution has seen an increase in the incorporation of ergonomic features by device designers aimed at increasing patient receptiveness. Recent inhaler designs have approached the goals of improved usability and patient adherence from a number of distinct directions, including dose preparation technology, dose packaging, novel formulation technology, dosing confirmation, and symptoms monitoring.

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

A comprehensive analysis of advanced feature devices for asthma drug therapeutics is included in a new and comprehensive report. The report, Asthma Inhalers – The New Generation: Devices, Markets, Players and Prospects , includes assessments of devices, device features and asthma therapeutic markets, analysis of market factors, and profiles of market participants.

More information is available at www.greystoneassociates.org

About Greystone

Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.

ENDS

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
 
 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.